Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFutura Medical Regulatory News (FUM)

Share Price Information for Futura Medical (FUM)

Share Price is delayed by 15 minutes
Get Live Data
0.37    -0.03 (-7.50%)
Bid:
0.36
Ask:
0.40
Spread: 0.04 (11.111%)
Market Cap: £2.15m
FUM Live PriceLast checked at - London Stock Exchange

Intraday Futura Medical Share Chart

Major Interest in Shares

16 Jan 2009 16:38

RNS Number : 8133L
Futura Medical PLC
16 January 2009
 



For Immediate Release

16 January 2009

Futura Medical plc

("Futura" or "the Group" or "the Company")

Notification of major interest in shares

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached

Futura Medical PLC

2. Reason for the notification 

Other (please specify): This notification is to reset the Allianz Group's reportable holdings to zero, following the sale of Dresdner Bank AG to the Commerzbank Group. A further notification will be submitted shortly, if appropriate, by the Allianz Group and/or Commerzbank Group, following a recalculation of the groups' interests.

YES

3. Full name of person(s) subject to the notification obligation:

Allianz SE

4. Full name of shareholder(s) (if different from 3.)

5. Date of the transaction (and date on which the threshold is crossed or reached if different)

12 January 2009

6. Date on which issuer notified:

13 January 2009

7. Threshold(s) that is/are crossed or reached:

7% 

8. Notified details:

A: Voting rights attached to shares

Class/type of shares 

if possible using the ISIN CODE

Situation previous to the Triggering transaction 

Resulting situation after the triggering transaction

Number of Shares 

Number of Voting Rights 

Number of shares 

Number of voting rights 

% of voting rights

Direct

Direct 

Indirect 

Direct

Indirect

GB0033278473

4,028,835

4,028,835

0

13. Additional information:

This notification is to reset the Allianz Group's reportable holdings to zero, following the sale of Dresdner Bank AG to the Commerzbank Group. A further notification will be submitted shortly, if appropriate, by the Allianz Group and/or Commerzbank Group, following a recalculation of the groups' interests. 

14. Contact name:

Dresdner Kleinwort Media Relations Team 

15. Contact telephone number:

020 7623 8000 

A: Identity of the person or legal entity subject to the notification obligation

Full name (including legal form for legal entities)

Allianz SE

Contact address (registered office for legal entities)

Koniginastrasse 28 

80802 Munich 

Germany

Phone number 

+49 89 38 00 00

Other useful information (at least legal representative for legal persons)

B:  Identity of the notifier, if applicable 

Full name 

Dresdner Kleinwort Group Limited

Contact address 

30 Gresham Street

London EC2V 7PG

Phone number 

020 7623 8000

Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation)

Subsidiary

  

For further information: 

Futura Medical plc

James Barder, Chief Executive

Tel: +44 (0) 1483 685 670

mail to: james.barder@futuramedical.co.uk

www.futuramedical.co.uk 

Canaccord Adams

Ryan Gaffney / Adria Da Breo Richards

Tel: +44 (0) 20 7050 6500 

For media enquiries please contact: 

Buchanan Communications

Mark Court / Rebecca Skye Dietrich / Stasa Filiplic

Tel: +44 (0) 20 7466 5000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLCKAKNABKDADD
Date   Source Headline
7th Jul 20264:15 pmRNSMED3000 (Eroxon®) European Patent Opposition
30th Jun 20265:02 pmRNSHolding(s) in Company
30th Jun 20267:00 amRNSHighly positive data from WSD4000 studies
29th Jun 20262:17 pmRNSCorrection: Result of AGM
29th Jun 20261:14 pmRNSResult of AGM
29th Jun 20267:00 amRNSNew US commercial partner
4th Jun 20267:00 amRNSNotice of AGM & availability of Annual Report
1st Jun 20263:30 pmRNSBlock Listing Six Monthly Return
22nd May 202612:06 pmRNSHolding(s) in Company
29th Apr 20267:00 amRNSUnaudited Results for the Year Ended 31 Dec 2025
20th Apr 20267:00 amRNSNotice of Results & Investor Presentation
23rd Mar 20267:00 amRNSPositive Eroxon® & Eroxon® “Intense” HUT results
18th Mar 20267:00 amRNSFormal Grant of US Patent
17th Mar 202611:37 amRNSHolding(s) in Company
20th Feb 20264:06 pmRNSHolding(s) in Company
5th Feb 20267:00 amRNSPatent notice of allowance granted for the US
4th Feb 20267:00 amRNSTrading Update
13th Jan 202612:53 pmRNSHolding(s) in Company
13th Jan 202612:51 pmRNSHolding(s) in Company
12th Jan 20267:00 amRNSResults of WSD4000 Early Feasibility Study
7th Jan 20264:34 pmRNSNotification of major holdings
31st Dec 20257:00 amRNSTotal Voting Rights
31st Dec 20257:00 amRNSTotal Voting Rights
30th Dec 20255:31 pmRNSNotification of major holdings
30th Dec 20255:31 pmRNSNotification of major holdings
23rd Dec 20254:37 pmRNSNotification of major holdings
23rd Dec 20254:37 pmRNSNotification of major holdings
18th Dec 20256:15 pmRNSNotification of major holdings
18th Dec 20256:15 pmRNSNotification of major holdings
18th Dec 20255:41 pmRNSNotification of major holdings
18th Dec 20255:41 pmRNSNotification of major holdings
12th Dec 20254:18 pmRNSNotification of major holdings
10th Dec 202512:01 pmRNSNotification of major holdings
10th Dec 202512:00 pmRNSNotification of major holdings
10th Dec 20257:00 amRNSPatent notice of allowance granted for China
9th Dec 20253:59 pmRNSBlock Listing Six Monthly Return
8th Dec 20251:34 pmRNSNotification of major holdings
8th Dec 202512:18 pmRNSDirectors' / PDMR dealing
4th Dec 20253:43 pmRNSNotification of major holdings
4th Dec 20253:41 pmRNSNotification of major holdings
3rd Dec 20257:00 amRNSBoard change
2nd Dec 202511:27 amRNSResult of General Meeting and Total Voting Rights
14th Nov 20254:40 pmRNSPCA Dealing
13th Nov 20254:35 pmRNSPosting of Circular and Notice of GM
13th Nov 20257:00 amRNSFundraise of £2.75 million
3rd Nov 202511:04 amRNSTotal Voting Rights
30th Sep 20257:00 amRNSResults for the six months ended 30 June 2025
26th Sep 202512:11 pmRNSNotice of Results and Investor Presentation
19th Sep 20257:00 amRNSTrading, Business and Strategic Review Update
29th Aug 20257:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.